FGFR1 and diffuse astrocytoma: The molecular alterations of these “pediatric-type” grade II diffuse astrocytomas were recently described and concerned the BRAF p.V600E mutation, FGFR1 alterations or MYB or MYBL1 rearrangement [13, 37].